STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.
@article{Pea2013STC1EB,
title={STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.},
author={Cristina Pe{\~n}a and Mar{\'i}a Virtudes C{\'e}spedes and Maja Bradic Lindh and Sara Kiflemariam and Artur Mezheyeuski and Per-Henrik D Edqvist and Christina H{\"a}ggl{\"o}f and Helgi Birgisson and Linda Bojmar and Karin Jirstr{\"o}m and Per Sandstr{\"o}m and Eleonor Olsson and Srinivas Veerla and Alberto Gallardo and Tobias Sj{\"o}blom and Andy C.-M. Chang and Roger R. Reddel and Ram{\'o}n Mangues and Martin Augsten and Arne Ostman},
journal={Cancer research},
year={2013},
volume={73 4},
pages={
1287-97
}
}Platelet-derived growth factor (PDGF) receptor signaling is a major functional determinant of cancer-associated fibroblasts (CAF). Elevated expression of PDGF receptors on stromal CAFs is associated with metastasis and poor prognosis, but mechanism(s) that underlie these connections are not understood. Here, we report the identification of the secreted glycoprotein stanniocalcin-1 (STC1) as a mediator of metastasis by PDGF receptor function in the setting of colorectal cancer. PDGF-stimulated…
Topics from this paper
113 Citations
Organ Specificity and Heterogeneity of Cancer-Associated Fibroblasts in Colorectal Cancer
- Biology, MedicineInternational journal of molecular sciences
- 2021
This review attempts to describe cellular features of colorectal CAFs with an emphasis on their heterogeneity and functional diversity in terms of their function, pathogenic role and cellular origin.
STC1 expression is associated with tumor growth and metastasis in breast cancer
- BiologyClinical & Experimental Metastasis
- 2014
This is the first study to show definitively that STC1 plays an oncogenic role in breast cancer, and indicates thatSTC1 could be a potential therapeutic target for treatment of breast cancer patients.
Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer
- Biology, MedicineFrontiers in Oncology
- 2021
It is found that Bcl9 depletion caused a pro-tumor effect of CAFs, while inhibition of abnormal activation of Wnt/β-catenin signal through BCL9 depletion benefited T-cell–mediated antitumor immune responses.
Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development
- BiologyCell reports
- 2020
PDGF receptors in tumor biology: prognostic and predictive potential.
- Biology, MedicineFuture oncology
- 2014
Data suggest that continued characterization of PDGFR expression in human tumors should present opportunities for improved accuracy in prognosis and also allow novel biomarker-based clinical studies exploring the efficacy ofPDGFR-directed tumor therapies.
Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer
- BiologyFront. Oncol.
- 2015
This review applies the metastasis-promoting communication of colorectal CAFs to 10 cancer hallmarks described by Hanahan and Weinberg to re-explore the potential messages implicated in this process.
PDGF receptors in tumor stroma: Biological effects and associations with prognosis and response to treatment.
- MedicineAdvanced drug delivery reviews
- 2017
Cancer-associated fibroblasts in digestive tumors.
- Biology, MedicineWorld journal of gastroenterology
- 2014
Increasing evidence has shown that spindle-shaped cancer-associated fibroblasts (CAFs) are a significant modifier of cancer evolution, and promote tumorigenesis, tumor invasion and metastasis by stimulating angiogenesis, malignant cell survival, epithelial-mesenchymal transition (EMT) and proliferation via direct cell-to-cell contact or secretion of soluble factors in most digestive solid tumors.
Stanniocalcin 1 in tumor microenvironment promotes metastasis of ovarian cancer
- Biology, MedicineOncoTargets and therapy
- 2019
The results revealed that STC1 promoted the phosphorylation of Akt (Ser473), and upregulated several epithelial–mesenchymal transition (EMT) markers including fibronectin,vimentin and slug, and demonstrated that STCs in tumor microenvironment could mediate the conversion of NFs to CAFs.
Snail1-expressing cancer-associated fibroblasts induce lung cancer cell epithelial-mesenchymal transition through miR-33b
- Biology, MedicineOncotarget
- 2017
Understanding the molecular mechanism underlying the communication between stromal cells and tumor cells mediated by miR-33b may lead to the identification of novel targets for the treatment of lung cancer and understanding the role of Snail1 driving CAFs to induce lung cancer cell EMT may provide with a new perspective on the treatmentof lung cancer.
References
SHOWING 1-10 OF 49 REFERENCES
Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.
- Medicine, BiologyCancer research
- 2009
Paracrine signaling by PDGF-CC is established as a potential drug target to reduce stromal support in malignant melanoma through recruitment and activation of different subsets of cancer-associated fibroblasts.
Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
- Medicine, BiologyPLoS medicine
- 2008
This study illustrates the therapeutic benefits in a mouse model of human cervical cancer of mechanism-based targeting of the stroma, in particular cancer-associated fibroblasts, which may prove complementary to conventional treatments targeting the overt cancer cells for a range of solid tumors.
Cancer-associated fibroblasts and tumor growth--bystanders turning into key players.
- BiologyCurrent opinion in genetics & development
- 2009
Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma.
- Biology, MedicineThe American journal of pathology
- 2006
It is demonstrated that blockade of PDGF-R signaling pathways in tumor-associated stromal cells and pericytes inhibits the progressive growth and metastasis of colon cancer cells.
PDGF receptors as targets in tumor treatment.
- Biology, MedicineAdvances in cancer research
- 2007
Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer
- Biology, MedicineProceedings of the National Academy of Sciences
- 2011
It is demonstrated that CAFs have greater ability than NFs to enhance the tumorigenicity of lung cancer cell lines and the prognostic impact of CAF-associated gene-expression changes in NSCLC patients is established.
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
- Medicine, BiologyProceedings of the National Academy of Sciences
- 2009
CXCL14 is identified as a novel autocrine stimulator of fibroblast growth and migration, with multi-modal tumor-stimulatory activities, and a novel mechanism whereby cancer-associated fibroblasts achieve their pro-tumorigenic phenotype is suggested.
Tumorigenic conversion of immortal human keratinocytes through stromal cell activation.
- Biology, MedicineProceedings of the National Academy of Sciences of the United States of America
- 1998
It is demonstrated that an activated stromal environment can promote tumorigenic conversion of nontumorigenic keratinocytes by inducing sustained epithelial hyperproliferation, apparently caused by a dual action of PDGF-BB.
Role of platelet-derived growth factors in physiology and medicine.
- Medicine, BiologyGenes & development
- 2008
Basic aspects of the PDGF ligands and receptors, their developmental and pathological functions, principles of their pharmacological inhibition, and results using PDGF pathway-inhibitory or stimulatory drugs in preclinical and clinical contexts are reviewed.
Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.
- Medicine, BiologyThe American journal of pathology
- 2009
The prognostic significance of stromal PDGF beta-receptor expression was particularly prominent in tumors from premenopausal women and should be considered in ongoing clinical development of PDGF receptor inhibitors.